Hepatitis C-Positive Organs for Liver and Kidney Transplantation—Emerging Data and Current Management Strategies.

Purpose of Review: We aim to review the current guidelines and emerging data and compare the pros and cons for the use of HCV-positive organs. Recent Findings: Some recent data suggests that the use of HCV-positive livers and kidneys safely increases the organ pool, additionally reducing wait list time, healthcare costs, and mortality. Summary: Despite this therapeutic breakthrough, the demand for organs and waitlist mortality remains high. Every year, thousands of viable hepatitis C-positive organs are discarded. The emerging data regarding transplantation of HCV-positive organs is promising; however, further research is warranted with larger samples. A literature search was conducted using PubMed, using the keywords "transplant recipients," "hepatitis C," "kidney transplantation," "liver transplantation," "direct acting antivirals," and "pre transplant." Only articles in the English language were included. [ABSTRACT FROM AUTHOR]